Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • Annual Defense Bill Would Require DoD to Establish AI Vulnerability Disclosure Program
    • N.D. Ill.: Help at Home must face core claims over patient data breach
    • Agencies Would Face Fewer Cyber Logging Obligations Under Revised OMB Directive
    • Cotton Warns FDA About Cyber Vulnerabilities in Chinese-Made Medical Devices
    • Legislation to Strengthen Privacy Protections for Children Advances in California
    • Minnesota Governor Signs Bill to Protect Youth on Social Media
    • South Korea Highlights Major Personal Information Dispute Cases
    • The Week in State Privacy and Cybersecurity Legislation—May 18-22, 2026
    • U.K., Australia to Collaborate on AI Cybersecurity Risks
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Cybersecurity Policy Report, Cotton Warns FDA About Cyber Vulnerabilities in Chinese-Made Medical Devices, (May 27, 2026)

    By Tom Leithauser

    Medical devices manufactured in China pose privacy and cybersecurity risks to U.S. patients and should receive special scrutiny from the Food and Drug Administration, according to Sen. Tom Cotton (R., Ark.), chairman of the Senate Intelligence Commit ...

    By Tom Leithauser

    Medical devices manufactured in China pose privacy and cybersecurity risks to U.S. patients and should receive special scrutiny from the Food and Drug Administration, according to Sen. Tom Cotton (R., Ark.), chairman of the Senate Intelligence Committee.

    “American patients' exposure to compromised Chinese-made medical devices poses a risk to both national security and public health,” Sen. Cotton said in a letter sent yesterday to Kyle Diamantas, the FDA’s acting commissioner.

    Sen. Cotton noted that the FDA started requiring medical device manufacturers “to demonstrate enhanced cybersecurity safeguards to receive FDA pre-market clearance in 2023” (CPR, Sept. 27, 2023).

    “But this requirement did not extend to medical devices on the market prior to the enactment of the enhanced cybersecurity requirements. Thus, more must be done to protect Americans from compromised medical devices,” he said.

    In 2025, the FDA and Cybersecurity and Infrastructure Security Agency issued a warning about data security vulnerabilities in a Chinese-made heart monitoring device, Sen. Cotton recalled.

    “The FDA found the device would automatically extract personally identifiable patient health information when connected to the internet. Data exfiltration of sensitive medical information can lead to widespread identity theft, insurance fraud, extortion, and more sophisticated scams against American patients,” Sen. Cotton told Mr. Diamantas.

    “CISA also warned the device was programmed to allow unverified users to remotely control the device without a health provider's knowledge. This gave malign Chinese actors an opportunity to directly manipulate how the device operates and displays data, potentially leading to dangerous misdiagnoses of heart failure, arrhythmias, and hypertension,” he said.

    “I respectfully ask the FDA and CISA to review Chinese-made medical devices cleared prior to March 29, 2023,” Sen. Cotton requested. “Protecting Americans' privacy and ensuring their health data isn't accessible to cybercriminals in adversarial nations is of utmost importance.”

    News: FederalLegislation DataSecurity DataPrivacy

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use